China plans to start opening its vaccination programme to members of the public in southwestern Sichuan province early next year, health officials said, despite the inoculations not yet receiving official approval.

At least one million people have already received a jab in China after vaccine candidates were approved for "emergency use", but so far they have been limited to priority groups such as state employees and international students.

China has five coronavirus vaccines in the final stages of development -- but none has received official approval from authorities and the results of late-stage trials have yet to be published.

A provincial health official told local media that vaccines will be provided to the general public in Sichuan after the Lunar New year holidays in February.

Officials said Thursday that 118,000 vaccine doses had arrived in the province so far, with plans to inoculate all high-risk groups by February 5 before rolling out the programme to the rest of the population.

They did not specify who developed the vaccines.

Sichuan is the first province to outline a timeline of its vaccination plans for the general public.

The coronavirus -- which first emerged in China late last year -- has largely been brought under control in the country, but there have been a series of domestic outbreaks.

Sichuan has been hit by a small cluster of Covid-19 cases in recent weeks, with one more virus infection reported Friday.

Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola

Tweet

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

China's Fosun Pharma to import 100 million BioNTech vaccine doses
Beijing (AFP) Dec 16, 2020
A Chinese pharmaceutical company said Wednesday it had agreed to buy at least 100 million doses of the coronavirus vaccine from German company BioNTech, subject to Beijing approving its use. China has been rapidly developing its own Covid-19 vaccine candidates and ramping up production facilities, but local firms have also been partnering with foreign developers to supply the world's most populous country. Shanghai Fosun Pharmaceutical Group said its subsidiary had entered into an agreement with ... read more